We are succesfully inspected by anvisa
Family-friendly workplace certification
An Investigation of Atropisomerism of Amenamevir and Its Intermediates by Dynamic HPLC
15 Supported Employer’S Informative Obligation
Development Of Manufacturing Technology For Three Pharmaceutical Ingredients
Establishment Of A Japanese Representative Office
We are proud to announce that our commercial partner Patriapharma established its Japanese subsidiary. Patriapharma Japan Co., Ltd. which was founded on 28/12/2020 and was created with the express purpose of meeting the strict Japanese regulations and providing exceptional customer support to our valued partners in Japan.
Our company organized summer camps for our employees and their children to alleviate the quarantine situation during the pandemic, which aims to replace the closed daycare during the summer period.
China based CF PharmTech, Inc. announced that it has raised US $50M in Series F financing following its US $90M Series E financing in January of 2020, in total, successfully completing an equity investment deal of nearly US $140M within six months.